Listen Here: For a full list of apps, go here. Or simply search “Sigma Nutrition” in your app of choice.Or listen directly on the Sigma website here. Introduction When discussing cardiovascular health, few topics stir as much debate as cholesterol, particularly in relation to low-carb and ketogenic diets. Recently, there’s been significant attention given to a proposed model that suggests high LDL cholesterol may not pose the same cardiovascular risk in certain individuals, specifically those labeled as “lean mass hyper-responders.” This raises important questions: Is it possible that high cholesterol might not be dangerous for everyone? Or are we witnessing …
#538: Can Fish Oil Supplementation Increase Risk of Irregular Heart Rhythms?
Listen Here: For a full list of apps, go here. Or simply search “Sigma Nutrition” in your app of choice.Or listen directly on the Sigma website here. Introduction Omega-3 fatty acids are often viewed as beneficial or, at worst, neutral supplements when it comes to supporting cardiovascular health, lowering triglycerides, and offering anti-inflammatory effects. Much of the focus in recent years has centered on understanding how significant these benefits are, particularly for heart health, with many studies highlighting the potential for omega-3s to play a positive role in reducing cardiovascular risk. However, an emerging concern has complicated the conversation around …
#534: Are Plant-Based Meat Alternatives Healthy? – Matthew Nagra, ND
The debate between animal-based and plant-based meat alternatives (PBMAs) has garnered significant attention, especially concerning their impact on cardiovascular health. As PBMAs become increasingly popular, questions about their nutritional profiles and long-term health implications have emerged. Are these alternatives genuinely healthier than traditional meat, or do their highly processed nature and high sodium content undermine potential benefits? This discussion is crucial as dietary choices increasingly influence public health policies and consumer behaviors.
#533: Making Sense of Omega-3 Supplement Trials – Prof. JoAnn Manson, MD, DrPH
In this episode, Professor JoAnn Manson will delve into the complexities of omega-3 research, discussing the VITAL trial in detail, comparing it with other significant studies, and providing insights into how to interpret and reconcile the diverse findings in the context of chronic disease risk.
#532: Dietary Fat: Evidence vs. Misinformation – Alice Lichtenstein, DSc
In the realm of nutrition science, few topics have sparked as much debate and evolution in understanding as the impact of dietary fat on cardiovascular health.
Dr. Alice Lichtenstein, a renowned expert in nutrition and cardiovascular disease, brings clarity to this complex field. Her extensive research at several prestigious institutions has been pivotal in shaping contemporary dietary guidelines.
#529: Addressing Popular Claims About Cholesterol, Dietary Fat and Heart Disease
In episode 529 of Sigma Nutrition Radio, we discuss all things related to cholesterol, atherosclerosis, heart disease, and dietary fat. The discussion extensively covers the impact of LDL cholesterol and ApoB on atherosclerotic plaque progression, cardiovascular events, and the benefits of early LDL lowering interventions, particularly through the use of PCSK9 inhibitors alongside statins.
#528: Is Unprocessed Red Meat Problematic for Our Health?
In this episode we delve into the contentious topic of unprocessed red meat and its potential health impacts. The episode addresses the common debates and confusion surrounding the risks associated with red meat consumption.
#527: How to Prevent & Treat Hypertension – Dr. Mohammed Alo, DO
In this episode, we are joined by Dr. Mohammed Alo, a board-certified cardiologist and internal medicine specialist, who will help us understand the intricacies of hypertension and how it can be effectively controlled.
#525: Cholesterol-Lowering Medication – Dr. Paddy Barrett
In this episode, preventative cardiologist Dr. Paddy Barrett discusses the different types of lipid-lowering medications, their mechanisms of action, the side effects that may occur, and the misconceptions about the drugs that are unfortunately widespread.
#521: How Does Coffee Impact Our Health?
The relationship between coffee and health is complex, encompassing areas like blood lipids, cardiovascular disease, neurodegenerative diseases, anxiety, and depression. Coffee has an interesting nutrient profile and contains diverse bioactive compounds that influence metabolism.
SNP28: How To Eat for Longevity
In a world flooded with claims, advice, and recommendations on how to extend our lifespan, the buzz around various diet approaches, supplement regimens, and lifestyle hacks is deafening. But amidst the noise, one must pause to ponder: Are these claims rooted in science? And perhaps more crucially, are we even asking the right questions or pursuing the correct goals in our quest for longevity?
Join us in our upcoming podcast episode as Danny delves into these intriguing questions. Rather than getting lost in the sea of trends and fads, Danny offers his insights on the essential inquiries we should be making. Discover how to shift our focus towards the core factors that genuinely enhance our chances of leading longer, healthier lives. Don’t miss out on this thought-provoking exploration into the science and philosophy behind longevity.
#515: Does Dietary Fat Quality Causally Affect Atherosclerosis Risk? – Jacob Christensen, PhD
Jacob J. Christensen is a clinical dietitian and researcher at University of Oslo. His research interests include cardiovascular diseases, lipid metabolism, nutrition, genomics and data science.
#514: Plant-derived Fatty Acids – Ella Baker, PhD
Dr. Baker’s research to date focuses on the metabolism, functionality, and underlying mechanisms of action of plant-derived fatty acids. Her interests include novel plant-derived fatty acids and exploring the effects on membrane structure and function.
#507: Does a Higher Portfolio Diet Score Reduce Heart Disease? – Andrea Glenn, PhD
The Portfolio diet is a nutritional approach that has garnered attention for its ability to reduce blood lipids and thus improve cardiovascular health.
Listener Q&A: Homocysteine, MUFA, Healhty BMI, and more! (SNP 24)
This episode is one of our Premium-exclusive AMA (ask me anything) episodes, where we answer questions submitted by Premium subscribers.
#505: Oslo Diet-Heart Study: Cholesterol-lowering Diets & Cardiovascular Events
The Oslo Diet-Heart Study was one of the earliest randomized controlled trials to explore the relationship between diet and heart disease. It aimed to investigate the impact of dietary interventions, specifically the reduction of saturated fat intake and an increase in polyunsaturated fat intake, on cardiovascular health.
The Oslo Diet-Heart Study involved 412 men who had already suffered a myocardial infarction 1-2 years before the start of the intervention.
Despite some known limitations, the Oslo Diet-Heart Study played a role in shaping early understanding on the relationship between dietary fat, cholesterol levels, and heart disease. Subsequent research and larger studies have contributed to a more nuanced understanding of the complex factors influencing cardiovascular health.
In this episode we discuss why this trial is important in the history of diet-heart research and how it connects to other seminal work in the field.
#504: Vegetable Oil vs. Saturated Fat – Analysis of the LA Veterans Study
In 1959 a landmark clinical trial, often referred to as the LA Veterans Study, began with the aim to investigate the effects of replacing dietary saturated fats with polyunsaturated fats, on the progression of atherosclerosis and cardiovascular outcomes.
#503: Lyon Diet Heart Study – Canola Oil, “Mediterranean” Diets & Minimizing Bias
The Lyon Diet Heart Study is often cited as one of the pivotal studies that helped establish the Mediterranean diet as a recognized and recommended dietary pattern for cardiovascular health. It showed significant reduction in cardiac death could be achieved in secondary prevention patients using a dietary intervention. Here we dig into some of the deatils.
#502: Sydney Diet-Heart Study – Is Linoleic Acid Causing Heart Disease?
Could this trial undermine the common conclusions that replacing saturated fat with polyunsatured fat decreases heart disease risk?
The PREDIMED Trial – Controversy, Criticisms, & Lessons Learned (SNP 22)
The study made a huge splash due to the rarity in nutrition of having large RCTs with hard endpoints. In addition, it had results of a large magnitude; showing a 30% reduction in cardiovascular events.
#494: Multiple Risk Factor Intervention Trial
The Multiple Risk Factor Intervention Trial (MRFIT) was a groundbreaking clinical trial conducted in the 1970s and 1980s. Its main objective was to investigate the relationship between various risk factors and the incidence of heart disease.
In this episode we take a look at why this is such seminal research, as well as the contribution of one of the greatest researchers ever in the field, Jeramiah Stamler.
#493: The Keys Equation – How Dietary Fats Impact Blood Cholesterol
One of the most important and influential papers in nutrition science is one by Ancel Keys and his colleagues that was published in The Lancet in 1957. This seminal paper examined the relationship between dietary fat intake and serum cholesterol levels. The most important aspect of this paper is the presentation of the ‘Keys Equation’; a predictive equation for the impacts of saturated, monounsaturated, and polyunsaturated fats, and dietary cholesterol, on blood cholesterol levels.
SNP20: The Cumulative Exposure Model of LDL-C & Heart Disease
It has been clearly demonstrated that elevated LDL-cholesterol (LDL-C), or perhaps more specifically pro-atherogenic lipoproteins, is causal in atherosclerosis development in humans. One crucial concept within this is that the risk relates not only to the magnitude of elevated LDL-C, but the duration of exposure. Thus, the role of LDL-C in driving atherosclerosis is referred to as a “cumulative, integrated exposure over the lifecourse”.
SNP19: AMA – Alan Flanagan, PhD
Ask Me Anything (AMA) episode with Dr. Alan Flanagan, PhD.
#481: Why Saturated Fat Really Does Impact Heart Disease Risk
While it has long been acknowledged that high intakes of saturated can increase risk of atherosclerotic cardiovascular disease due to their impact on blood lipids, there are some who question the association between saturated fat and heart disease.
Specifically, they may state that the evidence for this association is weak or non-existant, typically by pointing to some commonly cited studies that show null associations between saturated fat and CVD outcomes.
On this basis, they may conclude that there is no basis to aim to limit saturated fat intake to current recommended levels or that reducing saturated fat intake will not actually improve health outcomes.
In this episode, Alan and Danny look at the four most commonly cited publications showing a null association, highlighting some key issues. Beyond that, they look at a number of other lines of evidence on saturated fat that allows one to come to a confident answer on this question.
So does reducing saturated fat intake to recommended levels actually reduce heart disease risk? Let’s discuss…
SNP16: A Dairy Fat Paradox? – Saturated Fat, Food Matrices & Heart Disease
Substantial evidence shows that a high intake of saturated fat in the diet has the potential to significantly raise LDL-C and ApoB-containing lipoproteins in many people, and in turn increase their risk of developing atherosclerotic cardiovascular disease (ASCVD).
However, people may raise what seems to some contradictory evidence, or what is sometimes thought of as a paradox: the impact of full-fat dairy on CVD risk.
This paradox arises because given the saturated fat content of full-fat milk, yogurt and cheese, we typically don’t see the same impact on blood lipid profiles. In addition, epidemiology can often show such foods in a favourable light. And the dairy fat story gets more interesting when we look at evidence showing there is a huge difference in the impact of consuming different dairy foods (e.g. butter vs cheese/yogurt).
#477: Effect of Different Diets on Cholesterol, Lipoproteins and Discordance – Ian Davies, PhD
Introduction Discordance between low-density lipoprotein particle (LDL-p) and low-density lipoprotein cholesterol (LDL-C) occurs when the levels of these two biomarkers do not match up as expected. Discordance between Apolipoprotein B (ApoB) and low-density lipoprotein cholesterol (LDL-C) is similar, except rather than counting just LDL particles, ApoB is a measure of the numbers of lipoproteins that have an ApoB attached. Discordance between ApoB and LDL-C can lead to either an underestimate or overestimate of ASCVD risk. And therefore there may be important implications for someone who does have discordance. Additionally, it is such cases that suggest that a measurement of ApoB …
#457: Austin Robinson, PhD – Salt Sensitive vs Salt Resistant, Impacts of Sodium on Health, & Racial Differences in Risk
Introduction Hypertension (elevated blood pressure) is a condition that significantly increases the risk of several diseases and is a major cause of premature death worldwide. In the US, recent estimates suggest that about half of the adult population has hypertension. At a population level, high sodium intake is one of the main dietary risk factors. All population health guidelines recommend keeping sodium intake below certain levels. While, on average, blood pressure correlates with sodium intake, there is a wide range of responses on an individual level. People who see increasing sodium intake lead to increased blood pressure are termed “salt …
#451: Potassium & Blood Pressure: Influence of Sex & Sodium
It has been consistently shown in research that elevated dietary sodium consumption is associated with high blood pressure and an increased risk of cardiovascular disease. In addition, low levels of dietary potassium intake are associated with these same risks. However, there is some debate on how to characterize these relationships.
In a study published in European Heart Journal in July 2022, using data from the EPIC-Norfolk study, researchers attempted to answer whether the associations between potassium and both blood pressure and cardiovascular disease: 1) differ between men and women? and 2) depend on daily sodium intake.
In this episode Dr. Alan Flanagan and Danny Lennon discuss the details of this study and then link it to the overall evidence base and what this may mean for potassium (and sodium) intake considerations.
#439: Prof. David Jenkins – Lipid-Lowering Diets
Dr. David Jenkins and collegegues put forward the idea of a “portfolio” of specific nutrients/foods that could lower LDL-C further than the typical dietary changes. This became known as the Portfolio Diet. The four primary pillars of this portfolio diet are: soy protein, viscous fibers, nuts, and plant sterols.
#424: Is Low Cholesterol Bad For You?!
In this episode Alan and Danny discuss the role of cholesterol in the body and claims that are made suggesting low levels of blood cholesterol are harmful to health. Starting with the premise that cholesterol is an important molecule in the body and plays a role in many processes, the guys discuss two related claims: 1) we should avoid low cholesterol levels as it can harm our health, and 2) elevated levels of cholesterol may actually be protective against disease or mortality.
The episode also critiques claims about cholesterol being “conditionally essential” and that low LDL-C/ApoB increases risk of mortality, cancer and infection.
#415: Prof. Bruce Neal – Can Salt Substitutes Reduce Cardiac Events & Death?
Bruce Neal is Executive Director at The George Institute for Global Health Australia; and Professor of Medicine, UNSW Sydney. Bruce has a longstanding interest in high blood pressure and diabetes and the potential for both clinical interventions and changes in the food supply to deliver health gains.
#381: Prof. Chris Packard – LDL Cholesterol, ApoB & Atherosclerosis
Guest InformationProfessor Chris Packard Prof. Chris Packard holds an Honorary Professorship of Vascular Biochemistry at the University of Glasgow. Over his career, Professor Packard has focussed on two aspects of atherosclerosis research, lipoprotein metabolism and how it is affected by diets and drugs, and large-scale clinical trials of lipid lowering agents. He is acknowledged as one of the leading researchers in the world in this field. Prof Packard has published widely on the kinetics of apolipoprotein B and apolipoprotein A metabolism. Key contributions include evaluation of the role of the LDL receptor in vivo, the discovery of metabolic channelling in the …
#371: Dietary Cholesterol – Are Eggs & Cholesterol-rich Foods a Cause for Concern?
Today’s Topic in Focus: [00:51] In this episode Danny and Alan discuss the debate over the impact of dietary cholesterol on LDL-C levels and heart disease risk. Are eggs & cholesterol-rich foods a problem? Let’s dive into the research to find out! Referenced Material: Dietary Guidelines for Americans 2020 – 2025 Hegsted et al., 1993 – Dietary fat and serum lipids: an evaluation of the experimental data Human Atherosclerosis and the Diet – Ancel Keys Keys et al., 1965 – Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet Nakamura et al., 2013 …
#317: Understanding Diet & Heart Disease Risk
In This Episode We DiscussThis episode is a supplemental/follow-up episode to the ‘Diet & Cardiovascular Disease’ Series of Sigma Statements. If you have not read those statements, you can find them here: Cholesterol, Lipoproteins & Lipids: Understanding CVD Risk The Impact of Diet on Blood Lipids How Diet Influences Heart Disease Risk In this podcast Danny and Alan will be re-capping the main important points from each statement, in addition to addressing follow-up questions or potential conflicting points. We’ll cover issues such as: Does ApoB testing make LDL-C irrelevant? “I heard PUFA/omega-6 increases inflammation and therefore should be restricted. Is …
#315: Samia Mora, MD – Lipids, Lipoproteins & Atherosclerosis
Guest BioSamia Mora, MD, MHS Dr. Samia Mora is an Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts. She is a cardiovascular medicine specialist at the Brigham and Women’s Hospital, where she is the Director of the Center for Lipid Metabolomics. Dr. Mora’s research focuses on risk factors and prevention of cardiovascular disease. Dr. Mora received her undergraduate degree from Harvard University, and her medical degree from Harvard Medical School. She completed an internal medicine residency at Massachusetts General Hospital and a cardiovascular disease fellowship at The Johns Hopkins Hospital, where she also obtained a Masters in Health …